Remission & chronicity
Gene targets queried against DGIdb, Open Targets, ChEMBL, PubMed, and Europe PMC. Agents ranked: ● Clinical > ● Mechanistic > ● Correlative.
GABRA1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| CHLORDIAZEPOXIDE | ~ modulates | Mechanistic | DGIdb | |
| ETIFOXINE | ↓ inhibits | Mechanistic | DGIdb | |
| DIAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| METHARBITAL | ~ modulates | Mechanistic | DGIdb | |
| L838417 | ~ modulates | Mechanistic | DGIdb | |
| GANAXOLONE | ~ modulates | Mechanistic | DGIdb | |
| THIAMYLAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| EVT 201 | ? unclear | Mechanistic | DGIdb | |
| ADINAZOLAM | ? unclear | Mechanistic | DGIdb | |
| ZK-93423 | ? unclear | Mechanistic | DGIdb | |
| AMOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| ETHCHLORVYNOL | ~ modulates | Mechanistic | DGIdb | |
| SECOBARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| MEPHOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| ZOLPIDEM TARTRATE | ~ modulates | Mechanistic | DGIdb | |
| METHAQUALONE | ~ modulates | Mechanistic | DGIdb | |
| TOPIRAMATE | ~ modulates | Mechanistic | DGIdb | |
| PAGOCLONE | ~ modulates | Mechanistic | DGIdb | |
| THIOCOLCHICOSIDE | ? unclear | Mechanistic | DGIdb | |
| [3H]AZIETOMIDATE | ? unclear | Mechanistic | DGIdb | |
| PENTOBARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| MIDAZOLAM HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| TRIAZOLAM | ~ modulates | Mechanistic | DGIdb | |
| BARBITURATE | ? unclear | Mechanistic | DGIdb | |
| LORAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| BUTOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| TETRAHYDRODEOXYCORTICOSTERONE | ~ modulates | Mechanistic | DGIdb | |
| CLOTIAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| MEPROBAMATE | ↑ activates | Mechanistic | DGIdb | |
| [3H]CGS8216 | ~ modulates | Mechanistic | DGIdb | |
| PROPOFOL | ~ modulates | Mechanistic | DGIdb | |
| CLOBAZAM | ~ modulates | Mechanistic | DGIdb | |
| SEVOFLURANE | ~ modulates | Mechanistic | DGIdb | |
| METHOXYFLURANE | ~ modulates | Mechanistic | DGIdb | |
| LOREDIPLON | ~ modulates | Mechanistic | DGIdb | |
| CIPEPOFOL | ↑ activates | Mechanistic | DGIdb | |
| INDIPLON | ~ modulates | Mechanistic | DGIdb | |
| PHENOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| PRAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| CLORAZEPATE | ? unclear | Mechanistic | DGIdb |
Showing top 40 of 133 agents ranked by evidence tier.
GABRA2
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| METHARBITAL | ~ modulates | Mechanistic | DGIdb | |
| OCINAPLON | ? unclear | Mechanistic | DGIdb | |
| THIOPENTAL | ? unclear | Mechanistic | DGIdb | |
| DIAZEPAM | ~ modulates | Mechanistic | 17.0 nM (Ki) | DGIdb |
| PENTOBARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| FLUDIAZEPAM | ? unclear | Mechanistic | DGIdb | |
| ADINAZOLAM | ? unclear | Mechanistic | DGIdb | |
| ADIPIPLON | ↑ activates | Mechanistic | DGIdb | |
| TOPIRAMATE | ~ modulates | Mechanistic | DGIdb | |
| CLORAZEPATE DIPOTASSIUM | ~ modulates | Mechanistic | DGIdb | |
| ENFLURANE | ~ modulates | Mechanistic | DGIdb | |
| FLUNITRAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ETOMIDATE | ~ modulates | Mechanistic | DGIdb | |
| BUTOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| CLONAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ESZOPICLONE | ~ modulates | Mechanistic | DGIdb | |
| PHENOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| MEPROBAMATE | ↑ activates | Mechanistic | DGIdb | |
| PRIMIDONE | ~ modulates | Mechanistic | DGIdb | |
| ETIFOXINE | ↓ inhibits | Mechanistic | DGIdb | |
| FLURAZEPAM | ? unclear | Mechanistic | DGIdb | |
| TEMAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ALPRAZOLAM | ~ modulates | Mechanistic | 12.0 nM (EC50) | DGIdb |
| OXAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| SECOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| LORAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| PRAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| HALOTHANE | ~ modulates | Mechanistic | DGIdb | |
| FLUMAZENIL | ~ modulates | Mechanistic | 0.7943 nM (Ki) | DGIdb |
| BUTABARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| ABP-700 | ↑ activates | Mechanistic | DGIdb | |
| GANAXOLONE | ~ modulates | Mechanistic | DGIdb | |
| SECOBARBITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| HEXOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| ZOPICLONE | ~ modulates | Mechanistic | DGIdb | |
| DARIGABAT | ↑ activates | Mechanistic | DGIdb | |
| COCAINE | ? unclear | Mechanistic | DGIdb | |
| MEPHOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| TALBUTAL | ~ modulates | Mechanistic | DGIdb | |
| ACAMPROSATE CALCIUM | ~ modulates | Mechanistic | DGIdb |
Showing top 40 of 237 agents ranked by evidence tier.
GABRB3
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| METHOXYFLURANE | ~ modulates | Mechanistic | DGIdb | |
| QUAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| GABOXADOL | ↑ activates | Mechanistic | DGIdb | |
| CINOLAZEPAM | ? unclear | Mechanistic | DGIdb | |
| TOPIRAMATE | ~ modulates | Mechanistic | DGIdb | |
| HALOTHANE | ~ modulates | Mechanistic | DGIdb | |
| CLONAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| GLUTETHIMIDE | ~ modulates | Mechanistic | DGIdb | |
| CHLORDIAZEPOXIDE | ~ modulates | Mechanistic | DGIdb | |
| PRAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| PAGOCLONE | ~ modulates | Mechanistic | DGIdb | |
| TRIAZOLAM | ~ modulates | Mechanistic | DGIdb | |
| RESEQUINIL | ↓ inhibits | Mechanistic | DGIdb | |
| ETIFOXINE | ↓ inhibits | Mechanistic | DGIdb | |
| ESZOPICLONE | ~ modulates | Mechanistic | DGIdb | |
| MIDAZOLAM HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| PROPOFOL | ~ modulates | Mechanistic | DGIdb | |
| TEMAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ALPRAZOLAM | ~ modulates | Mechanistic | DGIdb | |
| ESTAZOLAM | ~ modulates | Mechanistic | DGIdb | |
| FOSPROPOFOL | ? unclear | Mechanistic | DGIdb | |
| ETHCHLORVYNOL | ~ modulates | Mechanistic | DGIdb | |
| LORAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ADIPIPLON | ↑ activates | Mechanistic | DGIdb | |
| CLOTIAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| FLUDIAZEPAM | ? unclear | Mechanistic | DGIdb | |
| TALBUTAL | ~ modulates | Mechanistic | DGIdb | |
| METHARBITAL | ~ modulates | Mechanistic | DGIdb | |
| CHLORMETHIAZOLE | ~ modulates | Mechanistic | DGIdb | |
| ETAZOLATE | ~ modulates | Mechanistic | DGIdb | |
| CIPEPOFOL | ↑ activates | Mechanistic | DGIdb | |
| HALAZEPAM | ~ modulates | Mechanistic | DGIdb | |
| ACAMPROSATE CALCIUM | ~ modulates | Mechanistic | DGIdb | |
| CHLORDIAZEPOXIDE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| FLUMAZENIL | ~ modulates | Mechanistic | DGIdb | |
| SEVOFLURANE | ~ modulates | Mechanistic | DGIdb | |
| METHOHEXITAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| METHYPRYLON | ~ modulates | Mechanistic | DGIdb | |
| THIAMYLAL SODIUM | ~ modulates | Mechanistic | DGIdb | |
| BROMAZEPAM | ? unclear | Mechanistic | DGIdb |
Showing top 40 of 109 agents ranked by evidence tier.
GRIN2A
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| PHILANTHOTOXIN 343 | ? unclear | Mechanistic | DGIdb | |
| AZD8108 | ↓ inhibits | Mechanistic | DGIdb | |
| RALFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CONANTOKIN-G | ↓ inhibits | Mechanistic | DGIdb | |
| NVP-AAM077 | ↓ inhibits | Mechanistic | DGIdb | |
| GW468816 | ↓ inhibits | Mechanistic | DGIdb | |
| APIMOSTINEL | ↑ activates | Mechanistic | DGIdb | |
| SELFOTEL | ↓ inhibits | Mechanistic | DGIdb | |
| MEMANTINE HYDROCHLORIDE | ~ modulates | Mechanistic | DGIdb | |
| FELBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| NEBOGLAMINE | ~ modulates | Mechanistic | DGIdb | |
| ZOLBETUXIMAB | ? unclear | Mechanistic | DGIdb | |
| GV196771A | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]CGP61594 | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]DIZOCILPINE | ↓ inhibits | Mechanistic | DGIdb | |
| (RS)-(TETRAZOL-5-YL)GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| PERZINFOTEL | ↓ inhibits | Mechanistic | DGIdb | |
| AV-101 | ↓ inhibits | Mechanistic | DGIdb | |
| GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| KETAMINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| MG2+ | ↓ inhibits | Mechanistic | DGIdb | |
| NERAMEXANE | ? unclear | Mechanistic | DGIdb | |
| D-AP5 | ↓ inhibits | Mechanistic | DGIdb | |
| NBQX | ? unclear | Mechanistic | DGIdb | |
| L701324 | ↓ inhibits | Mechanistic | DGIdb | |
| LANICEMINE | ↓ inhibits | Mechanistic | DGIdb | |
| NERAMEXANE MESYLATE | ↓ inhibits | Mechanistic | DGIdb | |
| CGP37849 | ↓ inhibits | Mechanistic | DGIdb | |
| ESKETAMINE | ~ modulates | Mechanistic | DGIdb | |
| INDANTADOL | ? unclear | Mechanistic | DGIdb | |
| D-CCPENE | ↓ inhibits | Mechanistic | DGIdb | |
| DEXANABINOL | ? unclear | Mechanistic | DGIdb | |
| [3H]D-ASPARTIC ACID | ↑ activates | Mechanistic | DGIdb | |
| TCN-201 | ~ modulates | Mechanistic | DGIdb | |
| LY233053 | ↓ inhibits | Mechanistic | DGIdb | |
| SAGE-718 | ~ modulates | Mechanistic | DGIdb | |
| (+)-HA966 | ↑ activates | Mechanistic | DGIdb | |
| NMDA | ↑ activates | Mechanistic | DGIdb |
Showing top 40 of 74 agents ranked by evidence tier.
GRIN2B
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| DIMIRACETAM | ? unclear | Mechanistic | DGIdb | |
| KETAMINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PERZINFOTEL | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]CGP39653 | ↓ inhibits | Mechanistic | DGIdb | |
| PHENCYCLIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| DEXANABINOL | ? unclear | Mechanistic | DGIdb | |
| RAPASTINEL | ↑ activates | Mechanistic | DGIdb | |
| DELUCEMINE | ↓ inhibits | Mechanistic | DGIdb | |
| AMANTADINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| RISLENEMDAZ | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| ELIPRODIL | ? unclear | Mechanistic | 13.0 nM (Ki) | DGIdb |
| INDANTADOL | ? unclear | Mechanistic | DGIdb | |
| SEVOFLURANE | ? unclear | Mechanistic | DGIdb | |
| SAGE-718 | ~ modulates | Mechanistic | DGIdb | |
| L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| ONFASPRODIL | ~ modulates | Mechanistic | DGIdb | |
| HOMOQUINOLINIC ACID | ↑ activates | Mechanistic | DGIdb | |
| NEBOGLAMINE | ~ modulates | Mechanistic | DGIdb | |
| DIZOCILPINE | ↓ inhibits | Mechanistic | DGIdb | |
| LY233053 | ↓ inhibits | Mechanistic | DGIdb | |
| GLYCINE | ↑ activates | Mechanistic | DGIdb | |
| ESKETAMINE | ~ modulates | Mechanistic | DGIdb | |
| [3H]CGP61594 | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]MDL105519 | ↓ inhibits | Mechanistic | DGIdb | |
| RADIPRODIL | ? unclear | Mechanistic | DGIdb | |
| NBQX | ? unclear | Mechanistic | DGIdb | |
| SEMAPIMOD | ↓ inhibits | Mechanistic | DGIdb | |
| SELFOTEL | ↓ inhibits | Mechanistic | DGIdb | |
| SERINE, D- | ↑ activates | Mechanistic | DGIdb | |
| COMPOUND 18C [PMID: 25901531] | ↓ inhibits | Mechanistic | DGIdb | |
| AZD8108 | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]L689560 | ↓ inhibits | Mechanistic | DGIdb | |
| TRAXOPRODIL | ↓ inhibits | Mechanistic | 74.0 nM (IC50) | DGIdb |
| HALOPERIDOL DECANOATE | ? unclear | Mechanistic | DGIdb | |
| N1-DANSYL-SPERMINE | ↓ inhibits | Mechanistic | DGIdb | |
| [3H]D-ASPARTIC ACID | ↑ activates | Mechanistic | DGIdb | |
| NERAMEXANE | ? unclear | Mechanistic | DGIdb | |
| NVP-AAM077 | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 238 agents ranked by evidence tier.
HCN1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| TRAMADOL | ? unclear | Mechanistic | DGIdb | |
| DESMETRAMADOL | ? unclear | Mechanistic | DGIdb | |
| CHEMBL2052019 | ↓ inhibits | Mechanistic | 158.49 nM (IC50) | ChEMBL |
| CHEMBL1823665 | ↓ inhibits | Mechanistic | 1258.93 nM (IC50) | ChEMBL |
| CHEMBL1823666 | ↓ inhibits | Mechanistic | 398.11 nM (IC50) | ChEMBL |
| CHEMBL1823667 | ↓ inhibits | Mechanistic | 630.96 nM (IC50) | ChEMBL |
| CHEMBL1823668 | ↓ inhibits | Mechanistic | 25118.86 nM (IC50) | ChEMBL |
| CHEMBL1823669 | ↓ inhibits | Mechanistic | 63095.73 nM (IC50) | ChEMBL |
| CHEMBL1823670 | ↓ inhibits | Mechanistic | 100000.0 nM (IC50) | ChEMBL |
| CHEMBL1823671 | ↓ inhibits | Mechanistic | 19952.62 nM (IC50) | ChEMBL |
| CHEMBL1823673 | ↓ inhibits | Mechanistic | 25118.86 nM (IC50) | ChEMBL |
| CHEMBL1823674 | ↓ inhibits | Mechanistic | 630.96 nM (IC50) | ChEMBL |
| CHEMBL1823675 | ↓ inhibits | Mechanistic | 50118.72 nM (IC50) | ChEMBL |
| CHEMBL1823676 | ↓ inhibits | Mechanistic | 15848.93 nM (IC50) | ChEMBL |
| CHEMBL1435630 | ↓ inhibits | Mechanistic | 398.11 nM (IC50) | ChEMBL |
| CHEMBL1823677 | ↓ inhibits | Mechanistic | 125.89 nM (IC50) | ChEMBL |
| CHEMBL1823678 | ↓ inhibits | Mechanistic | 63095.73 nM (IC50) | ChEMBL |
| CHEMBL1823874 | ↓ inhibits | Mechanistic | 15.85 nM (IC50) | ChEMBL |
| CHEMBL1823875 | ↓ inhibits | Mechanistic | 31.62 nM (IC50) | ChEMBL |
| CHEMBL1823876 | ↓ inhibits | Mechanistic | 251.19 nM (IC50) | ChEMBL |
| CHEMBL1823878 | ↓ inhibits | Mechanistic | 31.62 nM (IC50) | ChEMBL |
| CHEMBL1823879 | ↓ inhibits | Mechanistic | 50.12 nM (IC50) | ChEMBL |
| CHEMBL1823880 | ↓ inhibits | Mechanistic | 79.43 nM (IC50) | ChEMBL |
| CHEMBL1823881 | ↓ inhibits | Mechanistic | 199.53 nM (IC50) | ChEMBL |
| CHEMBL1823882 | ↓ inhibits | Mechanistic | 398.11 nM (IC50) | ChEMBL |
| CHEMBL1823883 | ↓ inhibits | Mechanistic | 15848.93 nM (IC50) | ChEMBL |
| CHEMBL1823885 | ↓ inhibits | Mechanistic | 1584.89 nM (IC50) | ChEMBL |
| CHEMBL1823886 | ↓ inhibits | Mechanistic | 398.11 nM (IC50) | ChEMBL |
| CHEMBL1823887 | ↓ inhibits | Mechanistic | 316.23 nM (IC50) | ChEMBL |
| CHEMBL1823888 | ↓ inhibits | Mechanistic | 630.96 nM (IC50) | ChEMBL |
| CHEMBL1823889 | ↓ inhibits | Mechanistic | 2511.89 nM (IC50) | ChEMBL |
| CHEMBL6195028 | ↓ inhibits | Mechanistic | 48.0 nM (IC50) | ChEMBL |
| CHEMBL6195037 | ↓ inhibits | Mechanistic | 40000.0 nM (IC50) | ChEMBL |
KCNQ2
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| GUANIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| TEDISAMIL | ↓ inhibits | Mechanistic | DGIdb | |
| DALFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| EZOGABINE | ↑ activates | Mechanistic | DGIdb | |
| AMIFAMPRIDINE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| ICA-105665 | ? unclear | Mechanistic | DGIdb | |
| FLINDOKALNER | ↑ activates | Mechanistic | DGIdb | |
| CELECOXIB | ? unclear | Mechanistic | DGIdb | |
| AMIFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb |
KCNQ3
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| EZOGABINE | ↑ activates | Mechanistic | 3900.0 nM (EC50) | DGIdb |
| AZETUKALNER | ↑ activates | Mechanistic | DGIdb | |
| DALFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| ICA-105665 | ? unclear | Mechanistic | DGIdb | |
| GUANIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CELECOXIB | ? unclear | Mechanistic | DGIdb | |
| GABAPENTIN | ↑ activates | Mechanistic | DGIdb | |
| LINOPIRDINE | ? unclear | Mechanistic | DGIdb | |
| FLINDOKALNER | ↑ activates | Mechanistic | 2400.0 nM (EC50) | DGIdb |
| TETRAMETHYLAMMONIUM | ↓ inhibits | Mechanistic | DGIdb | |
| AMIFAMPRIDINE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| TEDISAMIL | ↓ inhibits | Mechanistic | DGIdb | |
| AMIFAMPRIDINE | ↓ inhibits | Mechanistic | DGIdb | |
| CHEMBL4545892 | ↑ activates | Mechanistic | 10500.0 nM (EC50) | ChEMBL |
| CHEMBL4457044 | ↑ activates | Mechanistic | 920.0 nM (EC50) | ChEMBL |
KCNT1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| PHORBOL 12-MYRISTATE 13-ACETATE | ? unclear | Mechanistic | DGIdb | |
| NICLOSAMIDE | ↑ activates | Mechanistic | DGIdb | |
| QUINIDINE | ↓ inhibits | Mechanistic | 15800.0 nM (IC50) | DGIdb |
| LOXAPINE | ↑ activates | Mechanistic | DGIdb | |
| CLOFILIUM | ↓ inhibits | Mechanistic | DGIdb | |
| CHEMBL4793291 | ↓ inhibits | Mechanistic | 167.0 nM (IC50) | ChEMBL |
| CHEMBL4763819 | ↓ inhibits | Mechanistic | 3314.0 nM (IC50) | ChEMBL |
| CHEMBL4793050 | ↓ inhibits | Mechanistic | 11430.0 nM (IC50) | ChEMBL |
| CHEMBL4783466 | ↓ inhibits | Mechanistic | 335.0 nM (IC50) | ChEMBL |
| CHEMBL4789512 | ↓ inhibits | Mechanistic | 1597.0 nM (IC50) | ChEMBL |
| CHEMBL4779088 | ↓ inhibits | Mechanistic | 977.0 nM (IC50) | ChEMBL |
| CHEMBL4783741 | ↓ inhibits | Mechanistic | 136.0 nM (IC50) | ChEMBL |
| CHEMBL4759833 | ↓ inhibits | Mechanistic | 6489.0 nM (IC50) | ChEMBL |
| CHEMBL4750826 | ↓ inhibits | Mechanistic | 1373.0 nM (IC50) | ChEMBL |
| CHEMBL4777757 | ↓ inhibits | Mechanistic | 4466.0 nM (IC50) | ChEMBL |
| CHEMBL4786255 | ↓ inhibits | Mechanistic | 165.0 nM (IC50) | ChEMBL |
| CHEMBL4751954 | ↓ inhibits | Mechanistic | 5245.0 nM (IC50) | ChEMBL |
| CHEMBL4755742 | ↓ inhibits | Mechanistic | 11800.0 nM (IC50) | ChEMBL |
| CHEMBL4744857 | ↓ inhibits | Mechanistic | 1410.0 nM (IC50) | ChEMBL |
| CHEMBL4740667 | ↓ inhibits | Mechanistic | 2642.0 nM (IC50) | ChEMBL |
| CHEMBL4788669 | ↓ inhibits | Mechanistic | 27.0 nM (IC50) | ChEMBL |
| CHEMBL4781553 | ↓ inhibits | Mechanistic | 573.0 nM (IC50) | ChEMBL |
| CHEMBL4795194 | ↓ inhibits | Mechanistic | 454.0 nM (IC50) | ChEMBL |
| CHEMBL4743249 | ↓ inhibits | Mechanistic | 505.0 nM (IC50) | ChEMBL |
| CHEMBL4763955 | ↓ inhibits | Mechanistic | 16.0 nM (IC50) | ChEMBL |
| CHEMBL4750925 | ↓ inhibits | Mechanistic | 322.0 nM (IC50) | ChEMBL |
| CHEMBL4754084 | ↓ inhibits | Mechanistic | 61.0 nM (IC50) | ChEMBL |
| CHEMBL4793279 | ↓ inhibits | Mechanistic | 195.0 nM (IC50) | ChEMBL |
| CHEMBL4741793 | ↓ inhibits | Mechanistic | 40.0 nM (IC50) | ChEMBL |
| CHEMBL4776478 | ↓ inhibits | Mechanistic | 6282.0 nM (IC50) | ChEMBL |
| CHEMBL4745211 | ↓ inhibits | Mechanistic | 744.0 nM (IC50) | ChEMBL |
| CHEMBL4758890 | ↓ inhibits | Mechanistic | 778.0 nM (IC50) | ChEMBL |
| CHEMBL4744290 | ↓ inhibits | Mechanistic | 9285.0 nM (IC50) | ChEMBL |
| CHEMBL4750807 | ↓ inhibits | Mechanistic | 1876.0 nM (IC50) | ChEMBL |
| CHEMBL5218502 | ↓ inhibits | Mechanistic | 3200.0 nM (IC50) | ChEMBL |
| CHEMBL5219121 | ↓ inhibits | Mechanistic | 3000.0 nM (IC50) | ChEMBL |
| CHEMBL1730394 | ↓ inhibits | Mechanistic | 2400.0 nM (IC50) | ChEMBL |
| CHEMBL5219965 | ↓ inhibits | Mechanistic | 4900.0 nM (IC50) | ChEMBL |
| CHEMBL5218475 | ↓ inhibits | Mechanistic | 1400.0 nM (IC50) | ChEMBL |
| CHEMBL5220721 | ↓ inhibits | Mechanistic | 2400.0 nM (IC50) | ChEMBL |
Showing top 40 of 73 agents ranked by evidence tier.
MTOR
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| VISTUSERTIB | ↓ inhibits | Mechanistic | DGIdb | |
| EVEROLIMUS | ↓ inhibits | Mechanistic | DGIdb | |
| SIROLIMUS | ↓ inhibits | Mechanistic | 3.467 nM (IC50) | DGIdb |
| PYRROLIDINE DITHIOCARBAMATE | ? unclear | Mechanistic | DGIdb | |
| SU9516 | ? unclear | Mechanistic | DGIdb | |
| THAPSIGARGIN | ? unclear | Mechanistic | DGIdb | |
| CGS 15943 | ? unclear | Mechanistic | DGIdb | |
| RIDAFOROLIMUS | ↓ inhibits | Mechanistic | DGIdb | |
| PALOMID-529 | ↓ inhibits | Mechanistic | DGIdb | |
| PROPAFENONE | ? unclear | Mechanistic | DGIdb | |
| ZOTAROLIMUS | ? unclear | Mechanistic | 3.3 nM (IC50) | DGIdb |
| GEDATOLISIB | ↓ inhibits | Mechanistic | DGIdb | |
| TEMSIROLIMUS | ↓ inhibits | Mechanistic | DGIdb | |
| DS-3078A | ↓ inhibits | Mechanistic | DGIdb | |
| MTOR INHIBITOR | ? unclear | Mechanistic | DGIdb | |
| SYK INHIBITOR III | ? unclear | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL587620 | ? unclear | Mechanistic | DGIdb | |
| PF-04691502 | ↓ inhibits | Mechanistic | DGIdb | |
| LY-294002 | ? unclear | Mechanistic | 2500.0 nM (IC50) | DGIdb |
| ISOPROTERENOL | ? unclear | Mechanistic | DGIdb | |
| ME-344 | ? unclear | Mechanistic | DGIdb | |
| ALPELISIB | ↓ inhibits | Mechanistic | DGIdb | |
| SAMOTOLISIB | ↓ inhibits | Mechanistic | DGIdb | |
| PERPHENAZINE | ? unclear | Mechanistic | DGIdb | |
| MIBEFRADIL | ? unclear | Mechanistic | DGIdb | |
| TG100-115 | ? unclear | Mechanistic | DGIdb | |
| TAFA-93 | ? unclear | Mechanistic | DGIdb | |
| SF1126 | ↓ inhibits | Mechanistic | DGIdb | |
| SIROLIMUS ALBUMIN-BOUND NANOPARTICLES | ? unclear | Mechanistic | DGIdb | |
| GOSSYPOL | ? unclear | Mechanistic | DGIdb | |
| PHENETHYLISOTHIOCYANATE | ? unclear | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL599088 | ? unclear | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL600334 | ? unclear | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL591618 | ? unclear | Mechanistic | DGIdb | |
| CAFFEIC ACID PHENETHYL ESTER | ? unclear | Mechanistic | DGIdb | |
| DIPHENYLENEIODONIUM | ? unclear | Mechanistic | DGIdb | |
| CHEMBL:CHEMBL605077 | ? unclear | Mechanistic | DGIdb | |
| VANOXERINE | ? unclear | Mechanistic | DGIdb | |
| WIN55212-2 | ? unclear | Mechanistic | DGIdb | |
| SAPANISERTIB | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 324 agents ranked by evidence tier.
SCN1A
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| TETRACAINE | ↓ inhibits | Mechanistic | DGIdb | |
| PHENACEMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| RILUZOLE | ↓ inhibits | Mechanistic | DGIdb | |
| SAFINAMIDE | ? unclear | Mechanistic | DGIdb | |
| PHENYTOIN SODIUM | ↓ inhibits | Mechanistic | DGIdb | |
| MEPIVACAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CHLOROPROCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| ESLICARBAZEPINE ACETATE | ↓ inhibits | Mechanistic | DGIdb | |
| FLUOROURACIL | ? unclear | Mechanistic | DGIdb | |
| LIDOCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ETHOSUXIMIDE | ? unclear | Mechanistic | DGIdb | |
| FOSPHENYTOIN | ↓ inhibits | Mechanistic | DGIdb | |
| DISOPYRAMIDE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| RUFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| IRAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| TOPIRAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE SULFATE | ↓ inhibits | Mechanistic | DGIdb | |
| ETIDOCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| INDECAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| DYCLONINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE POLYGALACTURONATE | ↓ inhibits | Mechanistic | DGIdb | |
| ZONISAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LIDOCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| COCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| NITRAZEPAM | ? unclear | Mechanistic | DGIdb | |
| RALFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| HEXYLCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| PRILOCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| ENCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE GLUCONATE | ↓ inhibits | Mechanistic | DGIdb | |
| CLOBAZAM | ? unclear | Mechanistic | DGIdb | |
| TOCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PRIMIDONE | ↓ inhibits | Mechanistic | DGIdb | |
| ANTICONVULSANT AGENT | ? unclear | Mechanistic | DGIdb | |
| TETRODOTOXIN | ? unclear | Mechanistic | DGIdb | |
| MERETHOXYLLINE PROCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| PROPAFENONE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CENOBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| LACOSAMIDE | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 90 agents ranked by evidence tier.
SCN2A
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| PROCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PROPOFOL | ? unclear | Mechanistic | DGIdb | |
| OXCARBAZEPINE | ↓ inhibits | Mechanistic | DGIdb | |
| SAFINAMIDE | ? unclear | Mechanistic | DGIdb | |
| PROCAINAMIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PROPOXYCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| MERETHOXYLLINE PROCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| DISOPYRAMIDE PHOSPHATE | ↓ inhibits | Mechanistic | DGIdb | |
| TOCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| TOPIRAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| PRILOCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| CENOBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| NKTR-171 | ↓ inhibits | Mechanistic | DGIdb | |
| PHENYTOIN SODIUM | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE SULFATE | ↓ inhibits | Mechanistic | DGIdb | |
| TETRACAINE | ↓ inhibits | Mechanistic | 1100.0 nM (IC50) | DGIdb |
| DRONEDARONE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PHENAZOPYRIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| FOSPROPOFOL | ? unclear | Mechanistic | DGIdb | |
| RALFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ESLICARBAZEPINE ACETATE | ↓ inhibits | Mechanistic | DGIdb | |
| LIDOCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| MEPIVACAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LAMOTRIGINE | ↓ inhibits | Mechanistic | 10000.0 nM (IC50) | DGIdb |
| DYCLONINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| TETRODOTOXIN | ? unclear | Mechanistic | 14.0 nM (IC50) | DGIdb |
| MEXILETINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ZONISAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PHENOBARBITAL | ? unclear | Mechanistic | DGIdb | |
| LACOSAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| IRAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| FOSPHENYTOIN | ↓ inhibits | Mechanistic | DGIdb | |
| MORICIZINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| RILUZOLE | ↓ inhibits | Mechanistic | 2200.0 nM (IC50) | DGIdb |
| PHENACEMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| PROPAFENONE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| PRIMIDONE | ↓ inhibits | Mechanistic | DGIdb | |
| ENCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 248 agents ranked by evidence tier.
SCN8A
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| CHLOROPROCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| PRILOCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| PHENYTOIN SODIUM | ↓ inhibits | Mechanistic | DGIdb | |
| LACOSAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LIDOCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| RALFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ENCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LIDOCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| FOSPHENYTOIN | ↓ inhibits | Mechanistic | DGIdb | |
| CARBAMAZEPINE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE POLYGALACTURONATE | ↓ inhibits | Mechanistic | DGIdb | |
| IRAMPANEL | ↓ inhibits | Mechanistic | DGIdb | |
| ZANDATRIGINE | ? unclear | Mechanistic | DGIdb | |
| TOCAINIDE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| TETRACAINE | ↓ inhibits | Mechanistic | 520.0 nM (IC50) | DGIdb |
| MORICIZINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| SAFINAMIDE | ? unclear | Mechanistic | DGIdb | |
| ORPHENADRINE CITRATE | ↓ inhibits | Mechanistic | DGIdb | |
| NKTR-171 | ↓ inhibits | Mechanistic | DGIdb | |
| PRIMIDONE | ↓ inhibits | Mechanistic | DGIdb | |
| TOPIRAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| MERETHOXYLLINE PROCAINE | ↓ inhibits | Mechanistic | DGIdb | |
| ROPIVACAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| BENOXINATE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| EVENAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| HEXYLCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ARTICAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE GLUCONATE | ↓ inhibits | Mechanistic | DGIdb | |
| NERISPIRDINE | ↓ inhibits | Mechanistic | DGIdb | |
| MEPIVACAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| ETIDOCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| CENOBAMATE | ↓ inhibits | Mechanistic | DGIdb | |
| OXCARBAZEPINE | ↓ inhibits | Mechanistic | DGIdb | |
| PHENAZOPYRIDINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| MEXILETINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| LAMOTRIGINE | ↓ inhibits | Mechanistic | DGIdb | |
| RUFINAMIDE | ↓ inhibits | Mechanistic | DGIdb | |
| COCAINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| DYCLONINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| QUINIDINE SULFATE | ↓ inhibits | Mechanistic | DGIdb |
Showing top 40 of 238 agents ranked by evidence tier.
SLC6A1
| Therapeutic Agent | Effect Direction | Evidence Tier | Potency | Source |
|---|---|---|---|---|
| CI-966 | ? unclear | Mechanistic | DGIdb | |
| METADOXINE | ? unclear | Mechanistic | DGIdb | |
| COCAINE | ? unclear | Mechanistic | DGIdb | |
| TIAGABINE HYDROCHLORIDE | ↓ inhibits | Mechanistic | DGIdb | |
| HINOKININ | ? unclear | Mechanistic | DGIdb | |
| TIAGABINE | ? unclear | Mechanistic | Open Targets |
Recruiting and recently completed trials from ClinicalTrials.gov. Data retrieved 2026-07-06.
No recent clinical trials found on ClinicalTrials.gov for this condition.
Searched directly from “Epilepsy” via ClinicalTrials.gov interventions and Open Targets' disease→drug data — independent of the 14-gene target panel above. This surfaces agents whose mechanism doesn't route through a curated gene (combination therapies, standard-of-care drugs, targets outside the panel).
60 agents shown (approved or with trial evidence) — 52 not found by the gene-target search above.
Lacosamide
Approved · 6 trials · source: ClinicalTrials.gov, Open Targets
NCT02477839 NCT01484977 NCT00655551
Levetiracetam
Approved · 2 trials · source: ClinicalTrials.gov, Open Targets
NCT06393309 NCT00643500
topiramate
Approved · 2 trials · source: ClinicalTrials.gov, Open Targets
NCT00236730 NCT00236756
Emotion Memory TestingNOT in gene-target list
· 2 trials · source: ClinicalTrials.gov
NCT00486239 NCT00486239
Brivaracetam 2.5 mgNOT in gene-target list
· 2 trials · source: ClinicalTrials.gov
NCT00464269 NCT00464269
Vitamin ENOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00004637
Rufinamide
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01405053
Any other approved Antiepileptic DrugNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01405053
Wearable seizure prediction and alert glassesNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT07139457
Oral prednisoloneNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01575639
EEGNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06934356
Eye TrackingNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06934356
Behavioral taskNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06934356
fMRINOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06934356
Ganaxolone
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT04391569
Oxcarbazepine
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT00618046
ETX101NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06112275
Lyrica (pregabalin)NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00351611
Perampanel 10 MGNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06450236
Fycompa 10Mg TabletNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06450236
almotriptan malateNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00210509
Mandalas of EmotionsNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT04220333
Vitamin DNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT07085598
NIRSNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02899832
ZX008 0.2 or 0.8 mg/kg/dayNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT03355209
Matching PlaceboNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT03355209
Fish oil (Super Omega-3, 4 caps/d) vs. placeboNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00299533
MelatoninNOT in gene-target list
Phase 2/3 · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT05439876
ReACTNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02801136
Supportive TherapyNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02801136
Air polishing with erythritol powderNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06144034
Conventional treatmentNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06144034
Sodium valproateNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06393309
STARNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01851057
Education OnlyNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01851057
Activity Tracker GroupNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT04357912
Standard of Care GroupNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT04357912
DIXI Medical Microdeep® Micro- Macro Depth electrodesNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06105645
Standard electrodesNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06105645
Brivaracetam (ucb34714)NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00426673
Brain magnetic resonance imagingNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT04986683
Neuro-psychology testingNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT04986683
EEG/fMRINOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT03582345
nL-ATN1-002NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT07084311
NeuroPort micro-electrode arrayNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02932839
TLE Arm 1NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00486239
Emotion Memory TestNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00486239
Lamotrigine tabletNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00605371
Lamotrigine capletNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00605371
retigabine/ezogabineNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01587339
zonisamide
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01587339
pregabalinNOT in gene-target list
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01587339
eslicarbazepine
Approved · 1 trial · source: ClinicalTrials.gov, Open Targets
NCT01587339
SPN-817NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06798896
Dimension-Based Statistical LearningNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT05209386
Transcutaneous vagus nerve stimulation (Nemos®, Cerbomed GmbH)NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02409069
Sham stimulation (Nemos®, Cerbomed GmbH)NOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT02409069
Computer based task with EEGNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT06877260
Transcranial Direct Current StimulationNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT01415362
Brivaracetam 10 mgNOT in gene-target list
· 1 trial · source: ClinicalTrials.gov
NCT00464269